Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.330
+0.030 (2.31%)
At close: Apr 1, 2026, 4:00 PM EDT
1.330
0.00 (0.00%)
Pre-market: Apr 2, 2026, 4:09 AM EDT
Invivyd Employees
Invivyd had 122 employees as of December 31, 2025. The number of employees increased by 22 or 22.00% compared to the previous year.
Employees
122
Change (1Y)
22
Growth (1Y)
22.00%
Revenue / Employee
$437,918
Profits / Employee
-$430,238
Market Cap
375.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | 22 | 22.00% | 122 | 0 |
| Dec 31, 2024 | 100 | 5 | 5.26% | 99 | 1 |
| Dec 31, 2023 | 95 | 9 | 10.47% | 94 | 1 |
| Dec 31, 2022 | 86 | -17 | -16.50% | 84 | 2 |
| Dec 31, 2021 | 103 | - | - | 101 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Ginkgo Bioworks Holdings | 485 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 95 |
| PureTech Health | 56 |
| Candel Therapeutics | 55 |
| DiaMedica Therapeutics | 28 |
IVVD News
- 2 days ago - Invivyd Announces Presentation at the World Vaccine Congress Washington - GlobeNewsWire
- 12 days ago - Invivyd: A Logical Bull Thesis With A Major Catalyst Approaching - Seeking Alpha
- 27 days ago - Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates - GlobeNewsWire
- 27 days ago - Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer - GlobeNewsWire
- 4 weeks ago - Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026 - GlobeNewsWire
- 4 weeks ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies - GlobeNewsWire